Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Linagliptin CAS 668270-12-0

Linagliptin CAS 668270-12-0

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: COA,ISO

Model Number: CAS 668270-12-0

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 working days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: 1Ton/Month

Get Best Price
Highlight:
CAS No::
668270-12-0
Appearance::
White Or Off-white Crystalline Powder
Molecular Formula::
C25H28N8O2
Molecular Weight::
472.542
EINECS NO::
620-351-9
MDL NO::
MFCD14635356
CAS No::
668270-12-0
Appearance::
White Or Off-white Crystalline Powder
Molecular Formula::
C25H28N8O2
Molecular Weight::
472.542
EINECS NO::
620-351-9
MDL NO::
MFCD14635356
Linagliptin CAS 668270-12-0

Product Description:

Product Name: Linagliptin CAS NO:668270-12-0

 

 

Synonyms:

(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione;

 

 

Chemical & Physical Properties:

Appearance : White or off-white crystalline powder

Assay : No less than 99%

Melting point: 202℃

Density: 1.39/cm3

Boiling point: 661.189℃

Flash point: 353.675℃

Vapour Pressure: 0.0±2.0 mmHg at 25°C

Index of Refraction: 1.717

Category: Pharmaceutical raw material; Inhibitor;Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals; Pharmaceutical API.

 

 

Safety Information:

Safety Statements: S36/37

Risk Statements: R20/21/22

Hazard Codes: Xi

HS Code: 2933590090

 

 

 

Application:

1.Linagliptin(BI-1356) is an inhibitor of DPP-4, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

2. 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-3,7-dihydro-1H-purine-2,6-dione is an novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.

 

 

Our factory manufacture’s Linagliptin CAS 668270-12-0, mature technology, stable output, quality assurance.

Inventory Status : In Stock.

 

 

We can provide (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione certificate of analysis( COA), 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione MOA, 1H-Purine-2,6-dione,8-[(3R)-3-aMino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]- ROS, Linagliptin CAS 668270-12-0 MSDS and other support for you !

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.